These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10678938)

  • 21. Construction and characterization of Bordetella pertussis toxin mutants.
    Black WJ; Falkow S
    Infect Immun; 1987 Oct; 55(10):2465-70. PubMed ID: 2888733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular trafficking and membrane translocation of pertussis toxin into host cells.
    Veithen A; Raze D; Locht C
    Int J Med Microbiol; 2000 Oct; 290(4-5):409-13. PubMed ID: 11111919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
    J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.
    Gross MK; Au DC; Smith AL; Storm DR
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical analysis of mutations at tyrosine-98 of the S1 subunit of pertussis toxin.
    Xu Y; Barbieri JT
    Biochemistry; 1994 Feb; 33(6):1573-9. PubMed ID: 8312278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells.
    Carbonetti NH; Mays RM; Artamonova GV; Plaut RD; Worthington ZE
    BMC Microbiol; 2005 Feb; 5():7. PubMed ID: 15691377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a synthetic pertussis toxin operon in Escherichia coli.
    Pozza TD; Yan H; Walker MJ
    Vaccine; 1997 Jun; 15(9):968-75. PubMed ID: 9261943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Features of expression of the pertussis toxin operon under the control of its own and heterologous promotors in Bordetella bronchiseptica cells].
    Govorun VM; Ivanova VF; Kirillov MIu; Klitsunova NV; Nechaeva EV; Siniashina LN; Shumakov IuL; Karataev GI
    Mol Gen Mikrobiol Virusol; 1993; (2):21-7. PubMed ID: 8515746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of Pertussis toxin subunits.
    Sheu GC; Wo YY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.
    Nicosia A; Perugini M; Franzini C; Casagli MC; Borri MG; Antoni G; Almoni M; Neri P; Ratti G; Rappuoli R
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4631-5. PubMed ID: 2873570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+.
    Cieplak W; Locht C; Mar VL; Burnette WN; Keith JM
    Biochem J; 1990 Jun; 268(3):547-51. PubMed ID: 2363691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis.
    Stenson TH; Patton AK; Weiss AA
    Infect Immun; 2003 Mar; 71(3):1316-20. PubMed ID: 12595447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the promoter for the ptl genes of Bordetella pertussis, which encode proteins essential for secretion of pertussis toxin.
    Kotob SI; Hausman SZ; Burns DL
    Infect Immun; 1995 Aug; 63(8):3227-30. PubMed ID: 7622254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter of the pertussis toxin operon and production of pertussis toxin.
    Nicosia A; Rappuoli R
    J Bacteriol; 1987 Jun; 169(6):2843-6. PubMed ID: 2438270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pertussis toxin liberation genes of Bordetella pertussis are transcriptionally linked to the pertussis toxin operon.
    Ricci S; Rappuoli R; Scarlato V
    Infect Immun; 1996 Apr; 64(4):1458-60. PubMed ID: 8606119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
    Locht C; Antoine R
    Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis.
    Cheung AM; Farizo KM; Burns DL
    Infect Immun; 2004 Apr; 72(4):2057-66. PubMed ID: 15039327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.